Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1988 Oct;26(10):1983–1987. doi: 10.1128/jcm.26.10.1983-1987.1988

Isolation and characterization of mutant strains of Bordetella bronchiseptica lacking dermonecrotic toxin-producing ability.

H Nagano 1, T Nakai 1, Y Horiguchi 1, K Kume 1
PMCID: PMC266802  PMID: 3182989

Abstract

Mutant strains of Bordetella bronchiseptica, named B-42, B-76, B-84, and B-119, were obtained after serial passages of a parent strain, L3, on Bordet-Gengou agar plates containing 20% horse blood and 200 micrograms of nalidixic acid per ml (BGN-20 agar plates) at 42 degrees C. Mutant strains completely lacked dermonecrotic toxin-producing ability, and lethal activity of the strains for mice was apparently reduced compared with that of strain L3. Mutant strains were able to grow at 42 degrees C, and the strains were nalidixic acid resistant. The mutant strains showed domed (Dom+) colony morphology with smooth texture (Scs+) and no production of zone of hemolysis (Hly-), but the agglutinability of these strains to antiserum prepared with Dom+ Scs+ Hly+ organisms of strain L3 was the same as that of strain L3. When strain B-42 was inoculated intramuscularly or intranasally into guinea pigs, all the animals survived without manifesting clinical signs and produced a high-level of serum agglutination antibodies against strain L3. These inoculated animals were protected against intranasal challenge with strain L3. These properties of mutant strains are hereditarily stable after 50 subcultures on BGN-20 agar plates or 20 passages in mice. These data suggest that the mutant strains lacking dermonecrotic toxin-producing ability can be used as a live attenuated vaccine against swine atrophic rhinitis.

Full text

PDF
1983

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bemis D. A., Plotkin B. J. Hemagglutination by Bordetella bronchiseptica. J Clin Microbiol. 1982 Jun;15(6):1120–1127. doi: 10.1128/jcm.15.6.1120-1127.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brassinne M., Dewaele A., Gouffaux M. Intranasal infection with Bordetella bronchiseptica in gnotobiotic piglets. Res Vet Sci. 1976 Mar;20(2):162–166. [PubMed] [Google Scholar]
  3. Chladek D. W., Williams J. M., Gerber D. L., Harris L. L., Murdock F. M. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity. Am J Vet Res. 1981 Feb;42(2):266–270. [PubMed] [Google Scholar]
  4. Duncan J. R., Ross R. F., Switzer W. P., Ramsey F. K. Pathology of experimental Bordetella bronchiseptica infection in swine: atrophic rhinitis. Am J Vet Res. 1966 Mar;27(117):457–466. [PubMed] [Google Scholar]
  5. Farrington D. O., Switzer W. P. Parenteral vaccination of young swine against Bordetella bronchiseptica. Am J Vet Res. 1979 Oct;40(10):1347–1351. [PubMed] [Google Scholar]
  6. Goodnow R. A., Shade F. J., Switzer W. P. Efficacy of Bordetella bronchiseptica bacterin in controlling enzootic atrophic rhinitis in swine. Am J Vet Res. 1979 Jan;40(1):58–60. [PubMed] [Google Scholar]
  7. Hanada M., Shimoda K., Tomita S., Nakase Y., Nishiyama Y. Production of lesions similar to naturally occurring swine atrophic rhinitis by cell-free sonicated extract of Bordetella bronchiseptica. Nihon Juigaku Zasshi. 1979 Feb;41(1):1–8. doi: 10.1292/jvms1939.41.1. [DOI] [PubMed] [Google Scholar]
  8. Harris D. L., Switzer W. P. Immunization of pigs against Bordetella bronchiseptica infection by parenteral vaccination. Am J Vet Res. 1972 Oct;33(10):1975–1984. [PubMed] [Google Scholar]
  9. Ishikawa H., Isayama Y. Evidence for sialyl glycoconjugates as receptors for Bordetella bronchiseptica on swine nasal mucosa. Infect Immun. 1987 Jul;55(7):1607–1609. doi: 10.1128/iai.55.7.1607-1609.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kimman T. G., Kamp E. M. Induced atrophic rhinitis in rats. Am J Vet Res. 1986 Nov;47(11):2426–2430. [PubMed] [Google Scholar]
  11. Kume K., Nakai T., Samejima Y., Sugimoto C. Properties of dermonecrotic toxin prepared from sonic extracts Bordetella bronchiseptica. Infect Immun. 1986 May;52(2):370–377. doi: 10.1128/iai.52.2.370-377.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Maeda M., Shimizu T. Nasal infection of Alcaligenes bronchisepticus (Bordetella bronchiseptica) and lesions in newborn rabbits. Natl Inst Anim Health Q (Tokyo) 1975 Spring;15(1):29–37. [PubMed] [Google Scholar]
  13. Miniats O. P., Johnson J. A. Experimental atrophic rhinitis in gnotobiotic pigs. Can J Comp Med. 1980 Oct;44(4):358–365. [PMC free article] [PubMed] [Google Scholar]
  14. Nakagawa M., Shimizu T., Motoi Y. Pathology of experimental atrophic rhinitis in swine infected with Alcaligenes bronchisepticus or Pasteurella multocida. Natl Inst Anim Health Q (Tokyo) 1974 Summer;14(2):61–71. [PubMed] [Google Scholar]
  15. Nakai T., Kume K., Yoshikawa H., Oyamada T., Yoshikawa T. Adherence of Pasteurella multocida or Bordetella bronchiseptica to the swine nasal epithelial cell in vitro. Infect Immun. 1988 Jan;56(1):234–240. doi: 10.1128/iai.56.1.234-240.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nakai T., Kume K., Yoshikawa H., Oyamada T., Yoshikawa T. Changes in the nasal mucosa of specific-pathogen-free neonatal pigs infected with Pasteurella multocida or Bordetella bronchiseptica. Nihon Juigaku Zasshi. 1986 Aug;48(4):693–701. doi: 10.1292/jvms1939.48.693. [DOI] [PubMed] [Google Scholar]
  17. Nakai T., Sawata A., Kume K. Intracellular locations of dermonecrotic toxins in Pasteurella multocida and in Bordetella bronchiseptica. Am J Vet Res. 1985 Apr;46(4):870–874. [PubMed] [Google Scholar]
  18. Nakai T., Sawata A., Tsuji M., Kume K. Characterization of dermonecrotic toxin produced by serotype D strains of Pasteurella multocida. Am J Vet Res. 1984 Nov;45(11):2410–2413. [PubMed] [Google Scholar]
  19. Nakase Y., Takatsu K., Tateishi M., Sekiya K., Kasuga T. Heat-labile toxin of Bordetella pertussis purified by preparative acrylamide gel electrophoresis. Jpn J Microbiol. 1969 Dec;13(4):359–366. doi: 10.1111/j.1348-0421.1969.tb00479.x. [DOI] [PubMed] [Google Scholar]
  20. Oyamada T., Yoshikawa T., Yoshikawa H., Shimizu M., Nakai T., Kume K. Lesions induced in the nasal turbinates of neonatal pigs inoculated with Pasteurella multocia and/or Bordetella bronchiseptica. Nihon Juigaku Zasshi. 1986 Apr;48(2):377–387. doi: 10.1292/jvms1939.48.377. [DOI] [PubMed] [Google Scholar]
  21. Pedersen K. B., Barfod K. Effect of vaccination of sows with Bordetella bronchiseptica on the incidence of atrophic rhinitis in swine. Nord Vet Med. 1977 Sep;29(9):369–375. [PubMed] [Google Scholar]
  22. Peppler M. S. Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis. Infect Immun. 1982 Mar;35(3):840–851. doi: 10.1128/iai.35.3.840-851.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Peppler M. S., Schrumpf M. E. Phenotypic variation and modulation in Bordetella bronchiseptica. Infect Immun. 1984 Jun;44(3):681–687. doi: 10.1128/iai.44.3.681-687.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Roop R. M., 2nd, Veit H. P., Sinsky R. J., Veit S. P., Hewlett E. L., Kornegay E. T. Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine. Infect Immun. 1987 Jan;55(1):217–222. doi: 10.1128/iai.55.1.217-222.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sakano T., Sakurai K., Furutani T., Shimizu T. Immunogenicity and safety of an attenuated Bordetella bronchiseptica vaccine in pigs. Am J Vet Res. 1984 Sep;45(9):1814–1817. [PubMed] [Google Scholar]
  26. Sawata A., Kume K. Nasal turbinate atrophy in young mice inoculated with Bordetella bronchiseptica of pig origin. Am J Vet Res. 1982 Oct;43(10):1845–1847. [PubMed] [Google Scholar]
  27. Semjén G., Magyar T. A bovine haemagglutinin of Bordetella bronchiseptica responsible for adherence. Acta Vet Hung. 1985;33(3-4):129–136. [PubMed] [Google Scholar]
  28. Shade F. J., Goodnow R. A. Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine. Am J Vet Res. 1979 Sep;40(9):1241–1243. [PubMed] [Google Scholar]
  29. Shimizu T., Ishikawa H. Some characteristics of a urease-negative, temperature- sensitive strain of Bordetella bronchiseptica as a live, attenuated vaccine. Infect Immun. 1982 Apr;36(1):198–201. doi: 10.1128/iai.36.1.198-201.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shimizu T. Prophylaxis of Bordetella bronchiseptica infection in guinea pigs by intranasal vaccination with live strain ts-S34. Infect Immun. 1978 Nov;22(2):318–321. doi: 10.1128/iai.22.2.318-321.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smith I. M., Giles C. J., Baskerville A. J. Immunisation of pigs against experimental infection with Bordetella bronchiseptica. Vet Rec. 1982 May 22;110(21):488–494. doi: 10.1136/vr.110.21.488. [DOI] [PubMed] [Google Scholar]
  32. Yokomizo Y., Shimizu T. Adherence of Bordetella bronchiseptica to swine nasal epithelial cells and its possible role in virulence. Res Vet Sci. 1979 Jul;27(1):15–21. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES